Lobeck Medical AG increases sales by 45.5% to over 4 million CHF

01.10.2009 17:35

In the first half of the 2009 financial year, Lobeck Medical AG was able to generate an increase in sales of 45.5% to over 4 million CHF including the order backlog (previous year: 2.75 million CHF). EBIT increased by 126.3% to 215,000 CHF (previous year: 95,000 CHF).

Lobeck Medical AG has been listed on the Open Market of the Frankfurt Stock Exchange since August 2007. Under the brand name MediSmart® of Switzerland, it develops and sells product solutions for the medical diagnostics market, including blood glucose monitoring systems and home test products (in vitro diagnostics). 

“With an order backlog of around 1.9 million CHF as of June 30, 2009, the continuation of our positive business development is clearly evident,” explains Andreas Dornbierer, President of Lobeck Medical AG, and explains: “We currently see particular potential in home test products for the early detection of diseases.” The in vitro diagnostics field is experiencing annual growth rates of 10%.

The medical diagnostics market, in which Lobeck MedicalAG operates with the manufacture and sale of its blood glucose meters, shows annual growth of over 2.5%. In the area of diabetes control, Lobeck Medical AG focuses on the functional properties of its blood glucose meters for older people. “Due to the demographic development of the population, we see significantly increasing potential in this target group in the coming years. More and more people are developing adult-onset diabetes, which is why we tailor our products to the needs of older people, among other things,” explains Andreas Dornbierer.

MediSmart® blood glucose meters are produced in Switzerland. The Sapphire blood glucose meter is the latest model and is characterized by easy handling and a large LCD screen. It delivers precise results within 5 seconds.